Metanephrines in Obstructive Sleep Apnoea

Completed

• Conditions: Pheochromocytoma; Obstructive Sleep Apnea; Catecholamine; Secretion

• Registration Number: NCT05053685
• Lead Sponsor: Changi General Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-9-12
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Inclusion Criteria:<br><br> - Patients aged 21-70 years attending for a sleep study to evaluate for OSA<br><br>Exclusion Criteria:<br><br> - Medications that can cause changes in metanephrine levels<br><br> - Other factors that can cause changes in metanephrine levels<br><br> - Renal impairment (eGFR < 60ml/min)<br><br> - Other serious medical conditions

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Urine and plasma metanephrines;Urine and plasma metanephrines

Secondary Outcome Measures

Name	Time	Method
Relationship between metanephrine level and severity of OSA;Change in metanephrine levels with treatment for OSA